Staczek P - Search Results

1

Toxoplasma gondii: Serological recognition of reinfection.

Dzitko K, Staczek P, Gatkowska J, Dlugonska H. Dzitko K, et al. Among authors: staczek p. Exp Parasitol. 2006 Feb;112(2):134-7. doi: 10.1016/j.exppara.2005.09.010. Epub 2005 Nov 14. Exp Parasitol. 2006. PMID: 16289467

2

Carboranyl-1,8-naphthalimide intercalators induce lysosomal membrane permeabilization and ferroptosis in cancer cell lines.

Rykowski S, Gurda-Woźna D, Fedoruk-Wyszomirska A, Orlicka-Płocka M, Kowalczyk A, Stączek P, Denel-Bobrowska M, Biniek-Antosiak K, Rypniewski W, Wyszko E, Olejniczak AB. Rykowski S, et al. Among authors: staczek p. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2171028. doi: 10.1080/14756366.2023.2171028. J Enzyme Inhib Med Chem. 2023. PMID: 36715272 Free PMC article.

3

1,4-Disubstituted thiosemicarbazide derivatives are potent inhibitors of Toxoplasma gondii proliferation.

Dzitko K, Paneth A, Plech T, Pawełczyk J, Stączek P, Stefańska J, Paneth P. Dzitko K, et al. Among authors: staczek p. Molecules. 2014 Jul 9;19(7):9926-43. doi: 10.3390/molecules19079926. Molecules. 2014. PMID: 25010466 Free PMC article.

4

Biological evaluation and molecular modelling study of thiosemicarbazide derivatives as bacterial type IIA topoisomerases inhibitors.

Paneth A, Stączek P, Plech T, Strzelczyk A, Dzitko K, Wujec M, Kuśmierz E, Kosikowska U, Grzegorczyk A, Paneth P. Paneth A, et al. Among authors: staczek p. J Enzyme Inhib Med Chem. 2016;31(1):14-22. doi: 10.3109/14756366.2014.1003214. Epub 2015 Sep 4. J Enzyme Inhib Med Chem. 2016. PMID: 25792505

5

Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.

Dzitko K, Grzybowski MM, Pawełczyk J, Dziadek B, Gatkowska J, Stączek P, Długońska H. Dzitko K, et al. Among authors: staczek p. Parasit Vectors. 2015 Aug 15;8:422. doi: 10.1186/s13071-015-1019-7. Parasit Vectors. 2015. PMID: 26272689 Free PMC article.

6

Structural and serological studies of the O-polysaccharide of strains from a newly created Proteus O78 serogroup prevalent in Polish patients.

Drzewiecka D, Arbatsky NP, Staczek P, Shashkov AS, Knirel YA, Sidorczyk Z. Drzewiecka D, et al. Among authors: staczek p. FEMS Immunol Med Microbiol. 2010 Mar;58(2):269-76. doi: 10.1111/j.1574-695X.2009.00632.x. Epub 2009 Nov 11. FEMS Immunol Med Microbiol. 2010. PMID: 20002745 Free article.

7

Strains differentiation of Microsporum canis by RAPD analysis using (GACA)4 and (ACA)5 primers.

Dobrowolska A, Debska J, Kozłowska M, Staczek P. Dobrowolska A, et al. Among authors: staczek p. Pol J Microbiol. 2011;60(2):145-8. Pol J Microbiol. 2011. PMID: 21905632 Free article.

8

Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.

Drzewiecka D, Arbatsky NP, Shashkov AS, Staczek P, Knirel YA, Sidorczyk Z. Drzewiecka D, et al. Among authors: staczek p. FEMS Immunol Med Microbiol. 2008 Nov;54(2):185-94. doi: 10.1111/j.1574-695X.2008.00462.x. Epub 2008 Jul 28. FEMS Immunol Med Microbiol. 2008. PMID: 18665848 Free article.

9

[Bacterial type II topoisomerases as targets for antibacterial drugs].

Pietrusiński M, Staczek P. Pietrusiński M, et al. Among authors: staczek p. Postepy Biochem. 2006;52(3):271-82. Postepy Biochem. 2006. PMID: 17201062 Review. Polish.

10

Biological and docking studies of topoisomerase IV inhibition by thiosemicarbazides.

Siwek A, Stączek P, Wujec M, Stefańska J, Kosikowska U, Malm A, Jankowski S, Paneth P. Siwek A, et al. Among authors: staczek p. J Mol Model. 2011 Sep;17(9):2297-303. doi: 10.1007/s00894-010-0889-z. Epub 2010 Nov 16. J Mol Model. 2011. PMID: 21080016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page